2026-08-03Bullish
+20.39%weekly changeBaxter reported a Q2 2026 earnings beat, raised its full-year guidance, and benefited from a one-time tariff refund.
read the report →Baxter International Inc. is a global medtech leader focusing on advanced medical products and therapies, including drug compounding, IV solutions, and surgical equipment.
stitched from the price window carried by each report
Baxter reported a Q2 2026 earnings beat, raised its full-year guidance, and benefited from a one-time tariff refund.
read the report →Baxter reported Q2 2026 earnings beating consensus on revenue and EPS while raising its full-year 2026 guidance.
read the report →